Jane Street’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-104,300
Closed -$605K 10588
2024
Q3
$605K Sell
104,300
-2,400
-2% -$15.4K ﹤0.01% 6860
2024
Q2
$710K Sell
106,700
-1,300
-1% -$10.5K ﹤0.01% 6429
2024
Q1
$1.41M Buy
+108,000
New +$1.44M ﹤0.01% 4771
2023
Q2
Sell
-86,000
Closed -$2.17M 9563
2023
Q1
$2.17M Buy
86,000
+18,600
+28% +$437K ﹤0.01% 3688
2022
Q4
$1.55M Sell
67,400
-204,800
-75% -$4.72M ﹤0.01% 4266
2022
Q3
$6.01M Buy
+272,200
New +$5.27M ﹤0.01% 2331

Other funds holding TMCI

Jane Street's TMCI Position: Q1 2026 in Review

Jane Street sold out of Treace Medical Concepts (TMCI) in Q1 2026, closing a stake of 177,008 shares — an estimated $434K sold.

Jane Street first reported a position in TMCI in Q3 2022 and held it in 12 quarters. The position peaked at $1.31M in Q1 2023. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • Jane Street reported no remaining Treace Medical Concepts position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 177,008 Treace Medical Concepts shares in Q1 2026, an estimated $434K.
  • Jane Street first reported a position in Treace Medical Concepts in Q3 2022 and held it in 12 quarters.
  • Jane Street's Treace Medical Concepts position peaked at $1.31M in Q1 2023.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.